ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 24 filers reported holding ADIAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,185 | -40.5% | 29,705 | 0.0% | 0.00% | – |
| Q1 2023 | $10,397 | +62.8% | 29,705 | 0.0% | 0.00% | – |
| Q4 2022 | $6,387 | -36.1% | 29,705 | 0.0% | 0.00% | – |
| Q3 2022 | $10,000 | -75.0% | 29,705 | 0.0% | 0.00% | – |
| Q2 2022 | $40,000 | -32.2% | 29,705 | +1.4% | 0.00% | – |
| Q1 2022 | $59,000 | -25.3% | 29,299 | 0.0% | 0.00% | – |
| Q4 2021 | $79,000 | -37.3% | 29,299 | 0.0% | 0.00% | – |
| Q3 2021 | $126,000 | +125.0% | 29,299 | +34.0% | 0.00% | – |
| Q2 2021 | $56,000 | +107.4% | 21,873 | +82.7% | 0.00% | – |
| Q3 2020 | $27,000 | – | 11,974 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VANGUARD GROUP INC | 38,982 | $200,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 802 | $5,000 | 0.00% |
| UBS Group AG | 2,723 | $14,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 11,775 | $60,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 250 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 27,162 | $138,000 | 0.00% |
| MORGAN STANLEY | 545 | $3,000 | 0.00% |
| BlackRock Inc. | 205,684 | $1,053,000 | 0.00% |